Literature DB >> 6883293

Malignant melanoma of the skin. I. The association of tumor depth and type, and patient sex, age, and site with survival.

M S Blois, R W Sagebiel, R M Abarbanel, T M Caldwell, M S Tuttle.   

Abstract

The occurrence and behavior of cutaneous melanomas in a group of 1123 patients studied prospectively, is described in terms of histologic type, tumor thickness and levels of invasion, the patients' sex and age, and the anatomic location of the primary tumors. Associations amongst these attributes, and with survival, are also examined. The characteristics of the patients in this study (who on average are somewhat younger, and have better prognoses and survivals than those reported by most other groups) are compared with data obtained (primarily over the past decade) in other geographical areas, and with different patient populations. Evidence is presented that sex, tumor location, and age (in the case of males) are also predictive of survival.

Entities:  

Mesh:

Year:  1983        PMID: 6883293     DOI: 10.1002/1097-0142(19831001)52:7<1330::aid-cncr2820520732>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Pathology-important advances in clinical medicine: sexually transmitted gastrointestinal tract diseases.

Authors:  L D Ferrell
Journal:  West J Med       Date:  1984-07

2.  Pathology-important advances in clinical medicine: secondary diseases in immunosuppressed patients.

Authors:  J H Beckstead
Journal:  West J Med       Date:  1984-07

3.  Pathology-important advances in clinical medicine: prognostic features and the management of cutaneous malignant melanoma.

Authors:  R W Sagebiel
Journal:  West J Med       Date:  1984-07

4.  Tumor thickness is not a prognostic factor in thin melanoma.

Authors:  C Kuehnl-Petzoldt; S Fischer
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

5.  Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.

Authors:  S M Kheir; S D Bines; J H Vonroenn; S J Soong; M M Urist; J S Coon
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

6.  Should elective lymph node dissection be used for treatment of primary melanoma?

Authors:  B Biess; E B Bröcker; H Drepper; M Klein; A Lippold; A Peters
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

7.  Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.

Authors:  J W Kelly; R W Sagebiel; S Clyman; M S Blois
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

8.  The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma.

Authors:  J W Kelly; R W Sagebiel; W Calderon; L Murillo; R L Dakin; M S Blois
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

9.  In vitro quantification of melanoma tumor cell invasion.

Authors:  M J Hendrix; K R Gehlsen; H N Wagner; S R Rodney; R L Misiorowski; F L Meyskens
Journal:  Clin Exp Metastasis       Date:  1985 Oct-Dec       Impact factor: 5.150

10.  Evaluation of melanogenesis in A-375 cells in the presence of DMSO and analysis of pyrolytic profile of isolated melanin.

Authors:  Ewa Chodurek; Arkadiusz Orchel; Joanna Orchel; Sławomir Kurkiewicz; Natalia Gawlik; Zofia Dzierżewicz; Krystyna Stępień
Journal:  ScientificWorldJournal       Date:  2012-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.